BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 33929681)

  • 1. SSTR2 Expression in Olfactory Neuroblastoma: Clinical and Therapeutic Implications.
    Cracolici V; Wang EW; Gardner PA; Snyderman C; Gargano SM; Chiosea S; Singhi AD; Seethala RR
    Head Neck Pathol; 2021 Dec; 15(4):1185-1191. PubMed ID: 33929681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression of SSTR2 and P-STAT3 in human olfactory neuroblastoma].
    Zeng M; Cui Y; Wu C
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Aug; 24(15):690-2. PubMed ID: 20942237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcription Factor Expression in Sinonasal Neuroendocrine Neoplasms and Olfactory Neuroblastoma (ONB): Hyams' Grades 1-3 ONBs Expand the Spectrum of SATB2 and GATA3-Positive Neoplasms.
    Uccella S; Facco C; Chiaravalli AM; Pettenon F; La Rosa S; Turri-Zanoni M; Castelnuovo P; Cerati M; Sessa F
    Endocr Pathol; 2022 Jun; 33(2):264-273. PubMed ID: 35522392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcomes, Kadish-INSICA staging and therapeutic targeting of somatostatin receptor 2 in olfactory neuroblastoma.
    Lechner M; Takahashi Y; Turri-Zanoni M; Liu J; Counsell N; Hermsen M; Kaur RP; Zhao T; Ramanathan M; Schartinger VH; Emanuel O; Helman S; Varghese J; Dudas J; Riechelmann H; Sprung S; Haybaeck J; Howard D; Engel NW; Stewart S; Brooks L; Pickles JC; Jacques TS; Fenton TR; Williams L; Vaz FM; O'Flynn P; Stimpson P; Wang S; Hannan SA; Unadkat S; Hughes J; Dwivedi R; Forde CT; Randhawa P; Gane S; Joseph J; Andrews PJ; Royle G; Franchi A; Maragliano R; Battocchio S; Bewicke-Copley H; Pipinikas C; Webster A; Thirlwell C; Ho D; Teschendorff A; Zhu T; Steele CD; Pillay N; Vanhaesebroeck B; Mohyeldin A; Fernandez-Miranda J; Park KW; Le QT; West RB; Saade R; Manes RP; Omay SB; Vining EM; Judson BL; Yarbrough WG; Sansovini M; Silvia N; Grassi I; Bongiovanni A; Capper D; Schüller U; Thavaraj S; Sandison A; Surda P; Hopkins C; Ferrari M; Mattavelli D; Rampinelli V; Facchetti F; Nicolai P; Bossi P; Henriquez OA; Magliocca K; Solares CA; Wise SK; Llorente JL; Patel ZM; Nayak JV; Hwang PH; Lacy PD; Woods R; O'Neill JP; Jay A; Carnell D; Forster MD; Ishii M; London NR; Bell DM; Gallia GL; Castelnuovo P; Severi S; Lund VJ; Hanna EY
    Eur J Cancer; 2022 Feb; 162():221-236. PubMed ID: 34980502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calretinin staining facilitates differentiation of olfactory neuroblastoma from other small round blue cell tumors in the sinonasal tract.
    Wooff JC; Weinreb I; Perez-Ordonez B; Magee JF; Bullock MJ
    Am J Surg Pathol; 2011 Dec; 35(12):1786-93. PubMed ID: 22020045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical utility of somatostatin receptor scintigraphic imaging (octreoscan) in esthesioneuroblastoma: a case study and survey of somatostatin receptor subtype expression.
    Rostomily RC; Elias M; Deng M; Elias P; Born DE; Muballe D; Silbergeld DL; Futran N; Weymuller EA; Mankoff DA; Eary J
    Head Neck; 2006 Apr; 28(4):305-12. PubMed ID: 16470879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinicopathologic study of sinonasal teratocarcinosarcoma and its contrast with olfactory neuroblastoma].
    Li X; Liu HG; Xie XJ; Han YD; Li M
    Zhonghua Bing Li Xue Za Zhi; 2008 Jul; 37(7):458-64. PubMed ID: 19035117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequent expression of somatostatin receptor 2a in olfactory neuroblastomas: a new and distinctive feature.
    Czapiewski P; Kunc M; Gorczyński A; Haybaeck J; Okoń K; Reszec J; Lewczuk A; Dzierzanowski J; Karczewska J; Biernat W; Turri-Zanoni M; Castelnuovo P; Taverna C; Franchi A; La Rosa S; Sessa F; Klöppel G
    Hum Pathol; 2018 Sep; 79():144-150. PubMed ID: 29807052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinicopathological spectrum of olfactory neuroblastoma and sinonasal neuroendocrine neoplasms: Refinements in diagnostic criteria and impact of multimodal treatments on survival.
    Turri-Zanoni M; Maragliano R; Battaglia P; Giovannardi M; Antognoni P; Lombardi D; Morassi ML; Pasquini E; Tarchini P; Asioli S; Foschini MP; Sessa F; Nicolai P; Castelnuovo P; La Rosa S
    Oral Oncol; 2017 Nov; 74():21-29. PubMed ID: 29103747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Olfactory neuroblastoma with unusual structures: a clinical pathologic study].
    Yao Q; Yue CL; Lü ZC; Han YD; Liu HG
    Zhonghua Bing Li Xue Za Zhi; 2009 Mar; 38(3):163-8. PubMed ID: 19575850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression pattern of ISL-1, TTF-1 and PAX5 in olfactory neuroblastoma.
    Czapiewski P; Gorczyński A; Haybaeck J; Okoń K; Reszeć J; Skrzypczak W; Dzierżanowski J; Kunc M; Karczewska J; Biernat W
    Pol J Pathol; 2016 Jun; 67(2):130-5. PubMed ID: 27543867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent Wnt Pathway and ARID1A Alterations in Sinonasal Olfactory Carcinoma.
    Rooper LM; Agaimy A; Bell D; Gagan J; Gallia GL; Jo VY; Lewis JS; London NR; Nishino M; Stoehr R; Thompson LDR; Din NU; Wenig BM; Westra WH; Bishop JA
    Mod Pathol; 2024 May; 37(5):100448. PubMed ID: 38369189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the human Achaete-scute 1 gene in olfactory neuroblastoma (esthesioneuroblastoma).
    Carney ME; O'Reilly RC; Sholevar B; Buiakova OI; Lowry LD; Keane WM; Margolis FL; Rothstein JL
    J Neurooncol; 1995 Oct; 26(1):35-43. PubMed ID: 8583243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expressions of NeuroD and GAP43 as diagnostic markers for olfactory neuroblastoma.
    Furukawa T; Tatehara S; Teshima M; Shinomiya H; Inokuchi G; Komatsu M; Hara S; Zen Y; Nibu KI
    Auris Nasus Larynx; 2023 Jun; 50(3):358-364. PubMed ID: 35999123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytological diagnosis of olfactory neuroblastoma at metastatic sites, with emphasis on role of insulinoma-associated protein 1 immunocytochemistry.
    Roy D; Sriram S; Kakkar A; Kumar R; Kaur K; Jain D; Sharma A; Thakar A
    Diagn Cytopathol; 2023 Feb; 51(2):146-152. PubMed ID: 36369994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of sonic hedgehog signaling pathway in olfactory neuroblastoma.
    Mao L; Xia YP; Zhou YN; Dai RL; Yang X; Wang YJ; Duan SJ; Qiao X; Mei YW; Hu B
    Oncology; 2009; 77(3-4):231-43. PubMed ID: 19738389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Olfactory neuroblastoma (esthesioneuroblastoma) and esthesioneuroepithelioma: histologic and immunohistochemical study.
    Taraszewska A; Czorniuk-Sliwa A; Dambska M
    Folia Neuropathol; 1998; 36(2):81-6. PubMed ID: 9757618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Evidence for Olfactory Neuroblastoma as a Tumor of Malignant Globose Basal Cells.
    Zunitch MJ; Fisch AS; Lin B; Barrios-Camacho CM; Faquin WC; Tachie-Baffour Y; Louie JD; Jang W; Curry WT; Gray ST; Lin DT; Schwob JE; Holbrook EH
    Mod Pathol; 2023 May; 36(5):100122. PubMed ID: 36841178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study on pathological features and diagnosis, differential diagnosis of olfactory neuroblastoma].
    Liu HG; Zhang SZ; He CY
    Zhonghua Bing Li Xue Za Zhi; 2003 Oct; 32(5):432-6. PubMed ID: 14633455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Olfactory neuroblastoma: a review and update.
    Faragalla H; Weinreb I
    Adv Anat Pathol; 2009 Sep; 16(5):322-31. PubMed ID: 19700942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.